Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18508290 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites
Conditions: Ascites;   Liver Cirrhosis
Intervention: Drug: satavaptan (SR121463B)

Indicates status has not been verified in more than two years